UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 45

Sortiert nach

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

Molecular cancer therapeutics, 2018-06, Vol.17 (6), p.1156-1166

2018

Link zum Volltext

Verfügbarkeit prüfen

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

Nature communications, 2017-11, Vol.8 (1), p.1865-15, Article 1865

2017

Link zum Volltext

Verfügbarkeit prüfen

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells

Nucleic acids research, 2017-11, Vol.45 (19), p.11056

2017

Link zum Volltext

Verfügbarkeit prüfen

Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis

Breast cancer research and treatment, 2016-09, Vol.159 (2), p.215-227

2016

Link zum Volltext

Verfügbarkeit prüfen

The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation

Scientific reports, 2017-11, Vol.7 (1), p.16115-12, Article 16115

2017

Link zum Volltext

Verfügbarkeit prüfen

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

Nature communications, 2022-04, Vol.13 (1), p.2011-2011, Article 2011

2022

Link zum Volltext

Verfügbarkeit prüfen

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer

Cell reports (Cambridge), 2015-10, Vol.13 (1), p.108-121

2015

Link zum Volltext

Verfügbarkeit prüfen

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

Cell reports (Cambridge), 2015-08, Vol.12 (5), p.837-849

2015

Link zum Volltext

Verfügbarkeit prüfen

Histone Deacetylase Inhibitor Trichostatin A Represses Estrogen Receptor α-Dependent Transcription and Promotes Proteasomal Degradation of Cyclin D1 in Human Breast Carcinoma Cell Lines

Clinical cancer research, 2004-12, Vol.10 (23), p.8094-8104

2004

Link zum Volltext

Verfügbarkeit prüfen

Antiestrogens and their therapeutic applications in breast cancer and other diseases

Annual review of medicine, 2011-01, Vol.62 (1), p.217-232

2011

Link zum Volltext

Verfügbarkeit prüfen

Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer

Clinical cancer research, 2016-12, Vol.22 (23), p.5929-5938

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 1557: Defining modulators of response to samuraciclib, a CDK7 inhibitor for breast cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1557-1557

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract PD1-08: Esr1 mutant breast cancers show elevated basal cytokeratins and immune activation

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.PD1-08-PD1-08

2022

Link zum Volltext

Verfügbarkeit prüfen

LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner

Nucleic acids research, 2016-01, Vol.44 (2), p.582

2016

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2848: Neomorphic cell-cell adhesion reprogramming facilitates metastasis of ESR1 mutant breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2848-2848

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract GS1-05: Hotspot ESR1 mutations rewire cell-cell adhesome to facilitate breast cancer metastasis

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.GS1-05-GS1-05

2021

Link zum Volltext

Verfügbarkeit prüfen

Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor

Oncogene, 2004-09, Vol.23 (45), p.7561-7570

2004

Link zum Volltext

Verfügbarkeit prüfen

Prolonged exposure to bradykinin and prostaglandin E2 increases TRPV1 mRNA but does not alter TRPV1 and TRPV1b protein expression in cultured rat primary sensory neurons

Neuroscience letters, 2014-04, Vol.564, p.89-93

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract B44: Protein interactions involving LARP1 in chemotherapy resistant ovarian cancer cells

Cancer research (Chicago, Ill.), 2017-03, Vol.77 (6_Supplement), p.B44-B44

2017

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation

Scientific reports, 2018-03, Vol.8 (1), p.5237-1, Article 5237

2018

Link zum Volltext

Verfügbarkeit prüfen

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells

Nucleic acids research, 2013-12, Vol.41 (22), p.10228

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer

Breast cancer research and treatment, 2015-04, Vol.150 (3), p.511-522

2015

Link zum Volltext

Verfügbarkeit prüfen

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells

Journal of molecular endocrinology, 2013-12, Vol.51 (3), p.301-312

2013

Link zum Volltext

Verfügbarkeit prüfen

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells

Breast cancer research and treatment, 2011-06, Vol.127 (2), p.385-396

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(25)
Humans
(24)
Female
(17)
Breast Cancer
(15)
Oncology
(13)
Breast Neoplasms - Metabolism
(10)
Animals
(9)
Breast Neoplasms - Genetics
(9)
Breast Neoplasms - Pathology
(9)
Gene Expression
(9)
Gene Expression Regulation, Neoplastic
(9)
Tumors
(7)
Biochemistry & Molecular Biology
(6)
Biological And Medical Sciences
(6)
Cancer Research
(6)
Cancer Therapies
(6)
Cell Biology
(6)
Cell Line, Tumor
(6)
Estrogen
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Breast Cancer Research And Treatment
(8)
Cancer Research
(8)
Pflügers Archiv
(4)
Nucleic Acids Research
(3)
Cell Reports
(2)
Chemmedchem
(2)
Clinical Cancer Research
(2)
Nature Communications
(2)
Oncotarget
(2)
Scientific Reports
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells

Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis

The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer

LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer

Histone Deacetylase Inhibitor Trichostatin A Represses Estrogen Receptor α-Dependent Transcription and Promotes Proteasomal Degradation of Cyclin D1 in Human Breast Carcinoma Cell Lines

Antiestrogens and their therapeutic applications in breast cancer and other diseases

Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast Cancer

Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis

Abstract 1557: Defining modulators of response to samuraciclib, a CDK7 inhibitor for breast cancer

Abstract PD1-08: Esr1 mutant breast cancers show elevated basal cytokeratins and immune activation

LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner

Abstract 2848: Neomorphic cell-cell adhesion reprogramming facilitates metastasis of ESR1 mutant breast cancer

Abstract GS1-05: Hotspot ESR1 mutations rewire cell-cell adhesome to facilitate breast cancer metastasis

Silencing of androgen-regulated genes using a fusion of AR with the PLZF transcriptional repressor

Prolonged exposure to bradykinin and prostaglandin E2 increases TRPV1 mRNA but does not alter TRPV1 and TRPV1b protein expression in cultured rat primary sensory neurons

Abstract B44: Protein interactions involving LARP1 in chemotherapy resistant ovarian cancer cells

Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation

Co-regulated gene expression by oestrogen receptor α and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells

Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer

Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells

Suchergebnisse filtern